Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study (CNS Drugs, (2021), 35, 3, (305-316), 10.1007/s40263-021-00795-z)

Amichai Perlman, Rachel Goldstein, Lotan Choshen Cohen, Bruria Hirsh‑Raccah, David Hakimian, Ilan Matok, Yosef Kalish, Daniel E. Singer, Mordechai Muszkat*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

2 Scopus citations

Abstract

The article Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study, written by Amichai Perlman, Rachel Goldstein, Lotan Choshen Cohen, Bruria Hirsh‑Raccah, David Hakimian, Ilan Matok, Yosef Kalish, Daniel E. Singer, Mordechai Muszkat, was originally published Online First without Open Access. After publication in volume 35, issue 3, page 305–316 the author decided to opt for Open Choice and to make the article an Open Access publication.

Original languageEnglish
Pages (from-to)919
Number of pages1
JournalCNS Drugs
Volume35
Issue number8
DOIs
StatePublished - Aug 2021

Bibliographical note

Publisher Copyright:
© The Author(s) 2021

Fingerprint

Dive into the research topics of 'Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study (CNS Drugs, (2021), 35, 3, (305-316), 10.1007/s40263-021-00795-z)'. Together they form a unique fingerprint.

Cite this